Hinsch Gylvin Lykke bought PRQR
June 2, 2026 · Form 4 insider transaction
Hinsch Gylvin Lykke bought 14,495 shares of ProQR Therapeutics N.V. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
14,495
Price
$0.00
Total value
N/A
InsiderHinsch Gylvin Lykke
Role—
SecurityShare Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 2, 2026
Filing dateJune 3, 2026
Shares owned after14,495
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 2 is based upon the closing market price of the Issuer's ordinary shares on June 1, 2026, as determined pursuant to the Issuer's Board Compensation Policy.; 25% of the shares subject to such option vest and become exercisable on June 2, 2027, and the remaining 75% vest in 12 substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.